Yahoo! Finance Search - Finance Home - Yahoo! - Help

Thursday, January 29 2015 9:30am ET - U.S. Markets close in 6 hours and 30 minutes.
Industry Center - Drug Manufacturers - Other
Industry Center > Drug Manufacturers - Other > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Manufacturers - Other News
Latest News
Thursday, Jan 29, 2015
·Synergy Pharmaceuticals Completes Patient Enrollment for the Second Pivotal Phase 3 Trial of Plecanatide in Patients with Chronic Idiopathic Constipation
Business Wire - Thu 6:00 am ET
·Dr. Reddy’s Q3 and 9 Months FY15 Financial Results
Business Wire - Thu 5:12 am ET
Wednesday, Jan 28, 2015
·Correction: SciClone to Present at BIO CEO & Investor Conference on February 9, 2015 at 11 am ET
Marketwire - Wed 4:05 pm ET
·Consumer Groups Urge Europe not to Approve the Orexigen Diet Pill
at The Wall Street Journal Online - Wed 3:13 pm ET
·RegeneRx and G-treeBNT Create Joint Venture to Develop RGN-259 in the U.S.
PR Newswire - Wed 12:11 pm ET
·SciClone to Present at BIO CEO & Investor Conference on February 9, 2015
Marketwire - Wed 6:00 am ET
Tuesday, Jan 27, 2015
·Apricus Biosciences Announces Issuance of U.S. Patent for RayVa(TM)
GlobeNewswire - Tue 4:30 pm ET
·Deutsche Bank Offers Quick Thoughts On Teva Pharmaceutical's Generic Nexium
- Tue 9:33 am ET
Monday, Jan 26, 2015
·Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC
Business Wire - Mon Jan 26
·Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC
PR Newswire - Mon Jan 26
·[$$] Teva: FDA Approves Generic Version of AstraZeneca Heartburn Drug
at The Wall Street Journal Online - Mon Jan 26
·Is a Generic Nexium Purple Pill for You?
- Mon Jan 26
·Teva's generic version of AstraZeneca's Nexium gets FDA approval
at MarketWatch - Mon Jan 26
·Teva Receives FDA Approval for First Generic Nexium® Delayed-Release Capsules in the United States
Business Wire - Mon Jan 26
·Novo Nordisk stock rises 3%
at MarketWatch - Mon Jan 26
·Actavis to Buy Auden Mckenzie
at The Wall Street Journal Online - Mon Jan 26
·Trimel Announces Filing of NATESTO(TM) With Health Canada
Marketwire - Mon Jan 26
Friday, Jan 23, 2015
·Pfizer’s Deal Hunt Included Rebuffed Teva Approach
at Bloomberg - Fri Jan 23
·Double Chin? There May Be a Drug for That
at Bloomberg - Fri Jan 23
·EMA Recommends Hundreds of Drugs to be Suspended Over 'Flawed Studies'
at The Wall Street Journal Online - Fri Jan 23
More Latest News...
Sponsor Results
Oncology CRO
Oncology Phase Ib Expert Experience and Expertise
pharmatech.com
Clinical Trial Compliance
Experienced Healthcare Regulatory Compliance Consultants
www.debbiemcallister.com
Pharmaceutical Institute
High-impact training solutions for pharma and biotech
www.pharmainstitute.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Other Headlines
More Finance RSS Feeds


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?